1. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data, Nov 2016 Sub (2000-2014).
2. Cook MB, Drahos J, Wood S, et al. Pathogenesis and progression of oesophageal adenocarcinoma varies by prior diagnosis of Barrett’s oesophagus. Br J Cancer. 2016;115:1383–1390.
3. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Esophageal and Esophagogastric Junction Cancers. V.1.2017. Accessed at www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf on April 12, 2018.
4. Trivers KF, De Roos AJ, Gammon MD, et al. Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers. Clin Gastroenterol Hepatol. 2005;3:225–230.
5. Izzotti A, Carozzo S, Pulliero A, Zhabayeva D, Ravetti JL, Bersimbaev R. Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and prevention. Am J Cancer Res. 2016;6:1461–1493.